California State Teachers Retirement System (CalSTRS)
KNTE

California State Teachers Retirement System (CalSTRS)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,864
Closed -$67.9K – 3246
2023
Q1 		$67.9K Sell
10,864
-801
-7% -$4.88K ﹤0.01% 2781
2022
Q4 		$71.2K Buy
11,665
+131
+1% +$1.07K ﹤0.01% 2853
2022
Q3 		$138K Sell
11,534
-962
-8% -$12.6K ﹤0.01% 2712
2022
Q2 		$158K Sell
12,496
-7,854
-39% -$73.1K ﹤0.01% 2736
2022
Q1 		$229K Sell
20,350
-2,777
-12% -$30.6K ﹤0.01% 2620
2021
Q4 		$410K Buy
23,127
+290
+1% +$6.12K ﹤0.01% 2580
2021
Q3 		$526K Buy
22,837
+4,130
+22% +$89.9K ﹤0.01% 2451
2021
Q2 		$435K Sell
18,707
-1,678
-8% -$42.7K ﹤0.01% 2723
2021
Q1 		$635K Buy
+20,385
New +$710K ﹤0.01% 2414

Other funds holding KNTE

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s KNTE Position: Q2 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2023, closing a stake of 10,864 shares — an estimated $67.9K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in KNTE in Q1 2021 and held it in 9 quarters. The position peaked at $635K in Q1 2021. 72 funds tracked by Wall St. Rank hold KNTE as of Q2 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 10,864 Kinnate Biopharma Inc. Common Stock shares in Q2 2023, an estimated $67.9K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Kinnate Biopharma Inc. Common Stock position peaked at $635K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.